News summary
Japan's Kobayashi Pharmaceutical Health Products have been questioned, and more than 100 people have suffered health damage, with more than 70% of symptoms concentrated between late 2023 and early 2024.
Newsletter text
Japan's Kobayashi Pharmaceutical's health products trigger a health crisis, Japan's Ministry of Health, Labor and Welfare and Osaka City Government recently announcedpokerstarsliveA report on consumer health damagepokerstarsliveinvestigation report. According to the report, 2050 consumers developed health problems after taking health products containing red yeast ingredients. This survey data has attracted widespread attention in the market, especially those investors who have doubts about the safety of health products.
The survey showed that 1467 consumers were able to clearly point out the specific month in which health problems occurred, a figure that highlights the seriousness of the problem. It is worth noting that about 70% of the cases are concentrated between November 2023 and March 2024, which indicates that the health care products involved may have time-dependent problems.
